Literature DB >> 15327419

Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia.

Thomas Fehr1, Peter Ammann, Daniela Garzoni, Wolfgang Korte, Walter Fierz, Hans Rickli, Rudolf P Wüthrich.   

Abstract

BACKGROUND: Chronic renal failure leads to hyporegenerative anemia due to erythropoietin deficiency. The creatinine clearance and hemoglobin levels, at which anemia treatment with recombinant erythropoietin should be started, are unclear. Interpretation of serum erythropoietin levels in the context of renal insufficiency remains controversial and was addressed in this study.
METHODS: Three hundred and ninety-five patients were randomly chosen out of over 5000 consecutive patients investigated by coronary angiography at a single center between 1997 and 2001. Laboratory values and clinical information were prospectively collected in a central registry. Serum samples were frozen before angiography and now used to measure serum erythropoietin levels and evaluate the relationship between erythropoietin and hemoglobin levels in the context of various degrees of renal insufficiency.
RESULTS: The patients with the lowest renal function (creatinine clearance <20 mL/min) had significantly lower hemoglobin levels than the group with normal renal function. However, erythropoietin levels were identical indicating a lower set point for erythropoietin regulation. Above a creatinine clearance of 40 mL/min a significant inverse correlation between erythropoietin and hemoglobin levels was observed and described with the formula erythropoietin [U/L]= 2.5 x (140 - hemoglobin [g/L]) or alternatively Deltaerythropoietin (U/L) =-2.5 xDeltahemoglobin (g/L). Below 40 mL/min no significant correlation was found.
CONCLUSION: A cut-off level for an altered set point of erythropoietin regulation was determined at 40 mL/min creatinine clearance. Above this cut-off hemoglobin negatively regulates erythropoietin. Below the cut-off erythropoietin levels remain stable. Pathophysiologic concepts for this finding and clinical implications in patients with moderate renal failure are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327419     DOI: 10.1111/j.1523-1755.2004.00880.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Luciana Tanca; Maria Cristina Cherchi; Carlo Floris; Itaru Omoto; Antonio Barracca; Tomas Ganz
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

2.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

3.  Timing and determinants of erythropoietin deficiency in chronic kidney disease.

Authors:  Lucile Mercadal; Marie Metzger; Nicole Casadevall; Jean Philippe Haymann; Alexandre Karras; Jean-Jacques Boffa; Martin Flamant; François Vrtovsnik; Bénédicte Stengel; Marc Froissart
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-17       Impact factor: 8.237

4.  Anaemia in chronic kidney disease pregnancy.

Authors:  Adam Morton; Michael Burke; Anthony Morton; Sailesh Kumar
Journal:  Obstet Med       Date:  2020-09-01

5.  Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.

Authors:  Alejandro Balestracci; Marina Andrea Capone; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Laura Beaudoin; Jeanette Balbaryski; Lorena Gómez
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

6.  Prevalence of anemia according to stage of chronic kidney disease in a large screening cohort of Japanese.

Authors:  Kentaro Kohagura; Nozomi Tomiyama; Kozen Kinjo; Shuichi Takishita; Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2009-06-13       Impact factor: 2.801

7.  The Relation of Erythropoietin Towards Hemoglobin and Hematocrit in Varying Degrees of Renal Insufficiency.

Authors:  Mirsad Panjeta; Ismet Tahirovic; Jasenko Karamehic; Emin Sofic; Ognjen Ridic; Jozo Coric
Journal:  Mater Sociomed       Date:  2015-06-08

Review 8.  Microvascular pericytes in healthy and diseased kidneys.

Authors:  Szu-Yu Pan; Yu-Ting Chang; Shuei-Liong Lin
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-01-17

9.  Chapter 1: Diagnosis and evaluation of anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08

10.  Paraneoplastic Erythrocytosis of Colon Cancer, with Serum Erythropoietin within the Normal Reference Range.

Authors:  Hiromitsu Kitayama; Tomonhiro Kondo; Junko Sugiyama; Michiaki Hirayama; Yumiko Oyamada; Yasushi Tsuji
Journal:  Am J Case Rep       Date:  2016-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.